Trials / Unknown
UnknownNCT02618850
PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment
Study of the Role of Metabolic Response Measured by PET/CT Scan After 1 Cycle of First-line Therapy in Patients With Advanced Colorectal Cancer (CRC)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 260 (estimated)
- Sponsor
- National Cancer Institute, Naples · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test whether an early metabolic response, measured by PET/CT scan after the first cycle of chemotherapy, is able to predict which patients with advanced CRC have a better prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PET/CT | PET/CT scan at baseline and 10-14 days after day 1 of first cycle chemotherapy |
| DRUG | first-line chemotherapy | as prescribed by oncologist |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2015-12-02
- Last updated
- 2023-03-24
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02618850. Inclusion in this directory is not an endorsement.